Previously, edelfosine has been shown to inhibit PI3K/Akt survival pathway by displacing Akt as well as key regulatory kinases p-PDK1 (phosphatidylinositol-dependent protein kinase 1), PI3K and mTOR from lipid rafts in mantle cell lymphoma cells [33]. The gene discussed is MTOR; the disease is mantle cell lymphoma.